Apoptosis and proliferation: Correlation with p53 in astrocytic tumours

Journal of Neuro-Oncology

Volumn 73, Issue 2, 2005, Pages 93-100

  Sarkar, Chitra ^a   Karak, Asis Kumar ^a   Nath, Neera ^a   Sharma, Mehar Chand ^a   Mahapatra, Ashok Kumar ^a   Chattopadhyay, Parthoprasad ^a   Sinha, Subrata ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Astrocytic tumours; MIB 1LI; p53

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN P53;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL PROLIFERATION; CORRELATION ANALYSIS; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NICK END LABELING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEIN P53;

EID: 22144451105     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-3015-1     Document Type: Article

References (84)

1. CG Ferreira M Epping FAE Kruyt G Gaiccone 2002 Apoptosis: Target of cancer therapy Clin Cancer Res 8 2024-2034 1:CAS:528:DC%2BD38XmtVWit7w%3D 12114400
2. B Amirlak WT Couldwell 2003 Apoptosis in glioma cells: Review and analysis of techniques used for study with focus on the laser scanning cytometer J Neuro-Oncol 63 129-145 10.1023/A:1023906316524
3. G Majno I Joris 1995 Apotosis, oncosis and necrosis. An overview of cell death Am J Pathol 146 3-15 1:STN:280:ByqC28%2FhtFw%3D 7856735
4. SH Kaufmann GJ Gores 2002 Apoptosis in cancer: Cause and cure Bioessays 22 1007-1017 10.1002/ 1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4
5. I Pommepuy F Terro B Petit Trimoreau V Bellet S Robert J Hugon F Labrousse C Yardin A Brefeldin 2003 Induces apoptosis and cell cycle blockade in glioblastoma cell lines Oncology 64 4 459-467 10.1159/ 000070307 1:CAS:528:DC%2BD3sXktVyhur0%3D 12759546
6. RS Carrol J Zhang BW Chauncey K Chantziara MP Frosch PM Black 1997 Apoptosis in astrocytic neoplasm Acta Neurochir 139 845-850 10.1007/ BF01411402
7. DW Ellison PV Steart KC Gatter RO Weller 1995 Apoptosis in cerebral astrocytic tumour and its relationship to expression of the bcl-2 and p53 proteins Neuropathol Appl Neurobiol 21 352-361 1:CAS:528:DyaK2MXos1Glurk%3D 7494604
8. MA Heesters J Kousdstaal KG Go WM Molenaar 1999 Analysis of proliferation and apoptosis in brain gliomas: Prognostic and clinical value J Neurooncol 44 255-266 10.1023/A:1006398613605 1:STN:280:DC%2BD3c7otlWntQ%3D%3D 10720205
9. R Kordek M Hironishi PP Liberski R Yanagihara CD Gajdusek 1996 Apoptosis in glial tumours as determined by in situ non-radioactive labeling of DNA breaks Acta Neuro Pathol 91 112-116 10.1007/s004010050400 1:CAS:528:DyaK28XhtFyksrs%3D
10. S Nakagawa T Shiraishi S Kihara K Tabuchi 1995 Detection of DNA strand breaks associated with apoptosis in human brain tumours Virchows Arch 427 175-179 10.1007/BF00196523 1:CAS:528:DyaK2MXpvF2it70%3D 7582248
11. M Nakamura N Konishi S Tsunoda Y Hiasa T Tsuzuki T Invi T Sakaki 1997 Retinoblastom protein expression and MIB-1 correlate with survival of patients with malignant astrocytomas Cancer 80 242-249 10.1002/ (SICI)1097-0142(19970715)80:2<242::AID-CNCR12>3.0.CO;2-U 1:STN:280:ByiA28%2FgtV0%3D 9217037
12. Y Takekawa T Sawada I Sakurai 1999 Expression of apoptosis and its related protein in astrocytic tumours Brain Tumour Pathol 16 11-16 1:STN:280:DC%2BD3c%2FgtVaiug%3D%3D
13. A Nakamizo T Inamura K Ikezaki K Yoshimoto S Inoha M Mizoguch T Amano M Fukui 2002 Enhanced apoptosis in pilocytic astrocytoma: A comparative study of apoptosis and proliferation in astrocytic tumours J Neuro-Oncology 57 105-114 10.1023/A:1015705305540
14. AM Heesters J Koudstaal G Gwan WM Molenaar 2002 Proliferation and apoptosis in long term surviving low grade gliomas in relation to radiotherapy J Neuro-Oncol 58 157-165 10.1023/A:1016046125698
15. MJ Verstegen DT Leenstra H Ij lst-Keizers DA Bosch 2002 Proliferation and apoptosis - related proteins in intracranial ependymomas: An immunohistochemical analysis J Neurooncol 56 21-28 10.1023/ A:1014471714058 1:STN:280:DC%2BD383htl2gtA%3D%3D 11949823
16. D Schiffer R Ferracini P Cavalla 2001 Heterogeneity of apoptotic pathways and C. Jun/JNK expression in malignant gliomas Anticancer Res 21 2531-2535 1:CAS:528:DC%2BD3MXovVOqtL0%3D 11724318
17. TD Tlsty 2002 Functions of p53 supress critical consequences of damage and repair in the initiation of cancer Cell 2 1 2-4 10.1016/ S1534-5807(01)00112-5 1:CAS:528:DC%2BD38XlslOqs70%3D
18. SM Morris 2002 A role of p53 in the frequency and mechanism of mutation Mutat. Res. 511 45-62 10.1016/S1383-5742(01)00075-8 1:CAS:528:DC%2BD38XitFWrsr8%3D 11906841
19. C Prives PA Hall 1999 The p53 pathway J Pathol 187 112-126 10.1002/ (SICI)1096-9896(199901)187:1<112::AID-PATH250>3.3.CO;2-V 1:CAS:528:DyaK1MXmvVKrtQ%3D%3D 10341712
20. AJ Levine 1997 p53, the cellular gatekeeper for growth and division Cell 88 323-333 10.1016/S0092-8674(00)81871-1 1:CAS:528:DyaK2sXhtFahtLg%3D 9039259
21. DA Carson JM Ribeiro 1993 Apoptosis and disease Lancet 34 1251-1254 10.1016/0140-6736(93)91154-E
22. BW Stewart 1994 Mechanisms of apoptosis: Integration of genetic biochemical and cellular indicators J Natl Cancer Inst 86 1286-1296 1:CAS:528:DyaK2MXht1agt78%3D 8064887
23. AH Wyllie 1993 Apoptosis (The 1992 Frnk Rose memorial Lecture) Cancer 67 205-208 1:STN:280:ByyC2MbpvVE%3D
24. P Hainaut M Hollstein 2000 p53 and human cancer: The first ten thousand mutations Adv. Cancer Res 77 81-137 1:CAS:528:DC%2BD3cXltl2ktQ%3D%3D 10549356
25. MB Kastan O Oneykwere D Sidransky B Vogelstein RW Craig 1991 Participation of p53 protein in the cellular response to DNA damage Cancer Res 51 6304-6311 1:CAS:528:DyaK38XhvFSltg%3D%3D 1933891
26. SW Lowe T Jacks DE Housman HE Ruley 1994 Abrogation of oncogenes associated apoptosis allows transformation of p53 deficient cells Proc Natl Acad Sci 91 2026-2030 1:CAS:528:DyaK2cXitFCjurw%3D 8134344
27. G Fulki N Ishii EG Van Heir 1998 p53 and brain tumours - from gene mutations to gene therapy Brain Pathol 8 599-613 9804370
28. Cavenee WK, Funhari FB, Nagane M, Huang HJS, Newcomb EW, Bigner DD, Weller M, et al.: Diffusely infiltrating astrocytomas. In: Kleihunes P, Cavenee WK (eds) Pathology and Genetics of tumours of the Nervous System. IARC Press, Lyon pp. 10-21
29. EW Newcomb WJ Madonia S Pisharody FF Lang N Koslow DC Miller 1993 A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme Brain Pathol 3 229-235 1:CAS:528:DyaK2cXhs1Shs7Y%3D 8293182
30. M Nozaki M Tada H Kobayashi CL Zhang Y Sawamura H Abe N Ishii EG VanMeir 1999 Roles of functional loss of p53 and other genes in astrocytoma tumourigenesis and progression Neuro-Oncol 1 2 124-137 10.1215/ S1522851798000179 1:STN:280:DC%2BD3MrgtFCrsw%3D%3D 11550308
31. C Sarkar AM Talte MC Sharma VS Mehta 2002 Recurrent astrocytic tumours- a study of p53 immunoreactivity and malignant progression Br J Neurosurg 16 335-342 10.1080/02688697021000007588 1:STN:280:DC%2BD38njtFGjuw%3D%3D 12389885
32. P Birner M Piribauer I Fischer B Gatterbauer C Marosi K Ungersbock K Rossler H Budka JA Hainfellner 2002 Prognostic relevance of p53 protein expression in glioblastoma Oncol Rep 9 4 703-707 1:CAS:528:DC%2BD38XltlGku7w%3D 12066196
33. P Fei WS El-Deiry 2003 p53 and radiation responses Oncogene 22 5774-5783 10.1038/sj.onc.1206677 1:CAS:528:DC%2BD3sXmslemt7o%3D 12947385
34. FF Lang JM Bruner GN Fuller K Aldape MD Prados S Chang MS Bergen MW McDermott 2003 Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: Biological and clinical results J Clin Oncol 21 13 2508-2518 1:CAS:528:DC%2BD2cXptlCktrc%3D 12839017
35. P Chattopadhyay A Rathore M Mathur C Sarkar AK Mahapatra S Sinha 1997 Loss of heterozygosity of a locus on 17p13.3, independent of p53 is associated with higher grades of astrocytic tumours Oncogene 15 871-874 10.1038/sj.onc.1201238 1:CAS:528:DyaK2sXls1Krs78%3D 9266974
36. C Sarkar P Chattopadhyay 2003 Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumours Cancer Gen Cytogen 144 156-164 10.1016/S0165-4608(02)00937-8 1:CAS:528:DC%2BD3sXltF2htr8%3D
37. C Sarkar A Rathore P Chattopadhyay AK Mahapatra S Sinha 2000 Role of 17p13.3 chromosomal region in determining p53 protein immunopositivity in human astrocytic tumours Pathol 32 84-88 10.1080/003130200104286 1:CAS:528:DC%2BD3cXktVOls7k%3D
38. Kleihues P, Burger PC, Collins VP, Newcomb EV, Ohgaki H, Cavenee WK, Kleihues P, Cavenee WK: (eds) Tumours of the nervous system. World health Organization. Classification Tumours Eds: IARC press, Lyon, 2000
39. JP Steinbach M Weller 2002 Mechanism of apoptosis in central nervous system tumours: Application to theory Curr Neurol Neurosci Rep 2 3 246-253 11937003
40. J Ehrmann Jr. 2000 The expression of apoptosis related proteins and the apoptotic rate in glial tumours of the brain Neoplasma 47 151-155 1:CAS:528:DC%2BD3cXlvFyktr4%3D 11043837
41. D Casper 2000 Acetaminophen selectively reduces glioma cell growth and reduces radiosensitivity in culture J Neuro-Oncol 46 215-229 10.1023/ A:1006492423666 1:STN:280:DC%2BD3M%2Fjt1Chuw%3D%3D
42. C Chao S Saito J Kang 2000 p53 transcriptional activity is essential for p53 dependent apoptosis following Dna damage Embo J 19 18 4967-4975 10.1093/emboj/19.18.4967 1:CAS:528:DC%2BD3cXntVartLw%3D 10990460
43. GS Jimenez M Nister JM Stommel 2000 A tranactivation-deficient mouse model provides insight into Trp53 regulation and function Nat Genet 26 10 37-43 10.1038/79152 1:CAS:528:DC%2BD3cXmsVKkurc%3D 10973245
44. K Polyak Y Xia JL Sweier 1997 A model for p53 induced apoptosis Nature 389 300-305 10.1038/38525 1:CAS:528:DyaK2sXmtFGnsr4%3D 9305847
45. Y Haupt S Rowan E Shaulian K Vousden 1995 Induction of apoptosis in HeLa cells by trans-activation-deficient p53 Gene Dev 9 2170-2183 1:CAS:528:DyaK2MXotVOnu7k%3D 7657168
46. C Koumenis R Alarcon E Hammond 2001 Regulation of p53 by Hypoxia: dissociation of transcriptional repression and apoptosis from p53 dependent transactivation Mol Cell Biol 21 1297-1300 10.1128/ MCB.21.4.1297-1310.2001 1:CAS:528:DC%2BD3MXovVCmsg%3D%3D 11158315
47. C Friesen I Herr PH Krammer KM Debatin 1996 Involvement of the CD95 (AP0-1/FAS) receptor/ ligand system in drug induced apoptosis in leukemia cells Nat Med 2 574-577 10.1038/nm0596-574 1:CAS:528:DyaK28Xislyhs7s%3D 8616718
48. T Miyashita S Krajewski M Krajewska 1990 Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene 9 1799-1805
49. S Owen W Zhang JC Cusack 1995 Wild type human p53 and a temperature sensitive mutant induce Fas/APO-1 expression Mol Cell Biol 15 3032-3040 7539102
50. Mihara M, Erster S, Zaika A, Petrenko O, Chiteen den T, Pancoska P, Mool M: (2003). Mol. Cell. On line
51. E Bedner 2000 Translocation of Bax to mitochondria during apoptosis measured by laser scanning cytometry Cytometry 41 83-88 10.1002/ 1097-0320(20001001)41:2<83::AID-CYTO1>3.0.CO;2-R 1:CAS:528:DC%2BD3cXnsFWnsbc%3D 11002262
52. H Ikemoto 2000 Calphostin C-mediated translocation and integration of Bax into mitochondria induces cytochrome C release before mitochondrial dysfunction Cell Death Differ 7 511-520 10.1038/sj.cdd.4400682 1:CAS:528:DC%2BD3cXktFCltLw%3D 10822274
53. P Marchetti 1996 Mitochondrial permeability transition is a central coordinating event of apoptosis J Exp med 184 1155-1160 10.1084/ jem.184.3.1155 1:CAS:528:DyaK28XlsFartLY%3D 9064332
54. EA Slee 1999 Ordering the cytochrome C-initiated caspases cascade; hierarchical activation of caspases -2, -3, -6, -7 -8 and -10 in a caspase -9- dependent manner J cell Biol 144 282-292 10.1083/ jcb.144.2.281
55. T Glaser 2001 Death receptor-independent cytochrome C release and caspase activation mediate thymidine Kinase plus ganciclovir - mediated cytocoxicity in LN-18 and LN 229 human malignant glioma cells Gene Ther 8 469-476 10.1038/sj.gt.3301415 1:CAS:528:DC%2BD3MXitFaisrw%3D 11313826
56. N Shinoura 2000 Adenovirus mediated Overexpression of Fas induces apoptosis of gliomas Cancer Gene Ther 7 224-232 10.1038/sj.cgt.7700110 1:CAS:528:DC%2BD3cXit1ygsL0%3D 10770630
57. JA Kraus C Bolln HK Wolf J Neumann D Kinderman R Fimmers F Forster A Baumann U Schlegel 1994 TP53 alterations and clinical outcome in low grade astrocytomas Gene Chromosome Cancer 10 143-149 1:CAS:528:DyaK2MXjsVCntQ%3D%3D
58. DN Louis 1994 The p53 gene and protein in human brain tumours J Neuropathol Exp Neur 53 11-21 1:CAS:528:DyaK2cXis1Kqs7o%3D
59. K Watanabe O Tachibana K Sata Y Yonekawa P Kleihues H Ohgaki 1996 Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas Brain Pathol 6 217-223 1:STN:280:ByiD3Mjms1U%3D 8864278
60. KH Vousden 2000 p53 death star Cell 103 5 691-694 10.1016/ S0092-8674(00)00171-9 1:CAS:528:DC%2BD3cXos1Snuro%3D 11114324
61. DN Louis A won Deimling RY Chung 1993 Comparative study of p53 gene and protein alterations in human astrocytic tumours J Neuropathol Exp Neurol 52 31-38 1:STN:280:ByyC2cjotlw%3D 8381161
62. L Anker 1993 p53 protein accumulation and gene mutations in human glioma cell lines Int J Cancer 55 982-987 1:CAS:528:DyaK2cXis1Kqu7s%3D 8253536
63. AM Davidoff PA Humphrey JD Iglehart JR Marks 1991 Genetic basis for p53 overexpression in human breast cancer Proc Natl Acad Sci USA 88 5006-5010 1:CAS:528:DyaK3MXksVehtrc%3D 2052583
64. JR Marks AM Davidoff BJ Kerns 1991 Overexpression and mutation of p53 in epithelial ovarian cancer Cancer Res 51 2979-2984 1:STN:280:By6B3sritVE%3D 2032235
65. JAM Vet PP Brignuier HE Schaafsma 1995 Comparison of p53 protein overexpression with p53 mutation in bladder cancer: Clinical and biologic aspects Lab Invest 73 837-843 1:STN:280:BymC3cbht1U%3D 8558845
66. A Peraud WK Friedrich OD Wiestler 2002 Prognostic impact of p53 mutation and p53 protein overexpression in Supratentorial WHO Grade II astrocytomas and oliogoastrocytomas Clinical Cancer Res 8 1117-1124 1:CAS:528:DC%2BD38XksVSqu7g%3D
67. M Mizoguchi Inamura T T Shomo K Ikezaki S Inoha S Ohgami M Fukui 2002 A comparative study of apoptosis and proliferation in germinoma and glioblastoma J Neuro-Oncol 2 96-102
68. L Sach J Loten 1993 Control of programmed cell death in normal and leukemic cells: New implications for therapy Blood 82 15-81 8324219
69. CB Thompson 1995 Apoptosis in the pathogenesis and treatment of disease Science 276 1456-1462
70. IM Alderson RI Castleberg GRT Harsh DN Louis JW Henson 1995 Human gliomas with wild type p53 express bcl-2 Cancer Res 55 999-1001 1:CAS:528:DyaK2MXktVGitLs%3D 7867012
71. G Bellomo M Pertothi F Taddei F Mirabell G Finardi P Nicotera S Orrenivs 1992 Tumour necrosis factor alpha induces apoptosis in mammory adenocarcinoma cells by an increase in intranuclear free Ca 2+ concentration and DNA fragmentation Cancer Res 52 1342-1346 1:CAS:528:DyaK38XhsV2rs7s%3D 1737395
72. AR Clarke CA Purdie DJ Harrison RG Morris CC Bird ML Hooper AH Wyllie 1993 Thymocyte apoptosis induced by p53 dependent and independent pathways Nature 362 849-852
73. H Symonds L Krall L Remington M Saenz-Robles S Lowe T Jacks T Vandyke 1994 p53 dependent apoptosis suppress tumour growth and progression in vivo Cell 78 703-711 10.1016/0092-8674(94)90534-7 1:CAS:528:DyaK2cXlslKnsLc%3D 8069917
74. RH Rhodes 1998 Biological evaluations of biopsies from adult cerebral astrocytomas: Cell-growth/cell sucide rations and their relationship to patient survival J Neuropathol Exp Neur 57 746-757 1:STN:280:DyaK1czosFCntg%3D%3D
75. K Dietzmann P Von Bossanyi J Sallaba E Kirches HJ Synowitz M Warich-Kirches 1996 Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in astrocytic gliomas and their correlation to cell proliferation Gen Diagn Pathol 141 5-6 339-344 1:STN:280:BymA2svntVI%3D 8780933
76. P Korkolopoulou P Christodoulou K Kouzelizs M Hadjiyannakis A Priftis G Stamoulis A Seretis E Trhomas-Tsagli 1997 MDM2 and p53 expression in gliomas: A multivariate survival analysis including proliferation markers and epidermal growth factor receptor Br J Cancer 75 9 1269-1278 1:STN:280:ByiB1MbovFI%3D 9155045
77. T Tihan R Davis E Elowitz D Dicostanzo U Moll 2000 Practical value of Ki-67 and p53 labeling indices instereotactic biopsies of diffuse and pilocytic astrocytomas Arch pathol Lab Med 124 1 108-113 1:STN:280:DC%2BD3c%2FpsVKgsQ%3D%3D 10629140
78. D Schiffer P Cavalla A Migheli A Chio MT Giordana S Marino A Attanasio 1995 Apoptosis and cell proliferation in human neuroepithelial tumours Neurosci Lett 195 81-84 10.1016/0304-3940(95)11784-T 1:CAS:528:DyaK2MXntl2mu78%3D 7478273
79. E Patsouris P Davaki N Kapranos P Davaris K Papageorglou 1996 A study of apoptosis in brain tumours by in situ end labeling method Clin Neuropathol 15 337-341 1:STN:280:ByiD1M3htFE%3D 8937780
80. PK Lipponen S Aaltomaas 1994 Apoptosis in bladder cancer as related to standard prognositc factors and prognosis J Pathol 173 333-339 10.1002/ path.1711730408 1:STN:280:ByqD2MvntlM%3D 7965393
81. HH Ishii GC Gobe W Pan J YoneYama Y Ebihara 2002 Apoptosis and cell proliferation in the development of gastric carcinomas: Association with c-myc and p53 protein expression J Gastroenterol Hepatol 17 9 966-972 10.1046/j.1440-1746.2002.02805.x 1:CAS:528:DC%2BD38XotFKhsbY%3D 12167117
82. AJ Wagner JM Kokontis N Hay 1994 Myc mediated apoptosis requires wild type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 WAFI Genes Dev 8 2817-2830 1:CAS:528:DyaK2MXis1aisbY%3D 7995520
83. H Hermeking D Eick 1994 Mediation of c-Myc-induced apoptosis by p53 Science 265 5181 2091-3009 1:CAS:528:DyaK2cXmt1Ogurs%3D 8091232
84. VS Prasad RE LaFond M Zhou KA Jacobsen DG Osmond CL Sidman 1997 Upregulation of endogenous p53 and induction of in vivo apoptosis in β-lineage lymphomas of E(mu)-myc transgenic mice by deregulated c-myc transgene Mol Carcinog 18 2 66-77 10.1002/ (SICI)1098-2744(199702)18:2<66::AID-MC2>3.0.CO;2-O 1:CAS:528:DyaK2sXhsFKgt7Y%3D 9049182